CAR T cell therapy: newer approaches to counter resistance and cost

CAR T cell therapy: newer approaches to counter resistance and cost

The genetically engineered Chimeric Antigen Receptor bearing T-cell (CAR T cell) therapy has been emerged as the new paradigm of cancer immunotherapy. However, recent studies have reported an increase in the number of relapsed haematological malignancies. This review provides newer insights into how...

Full description

Bibliographic Details
Main Authors: Rajesh Kumar Yadav, Asgar Ali, Santosh Kumar, Alpana Sharma, Basab Baghchi, Pritanjali Singh, Sushmita Das, Chandramani Singh, Sadhana Sharma
Format: Article
Language:English
Published: Elsevier 2020-04-01
Series:Heliyon
Subjects:
Immunotherapy
CAR T cells
Tumor mutation burden
Epigenetics
Combination therapy
Affordable
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844020306241

Internet

http://www.sciencedirect.com/science/article/pii/S2405844020306241

Similar Items